FOLH1 and prostate neoplasm: Essa et al. [100] prepared Quercetin-loaded Poly Lactic-co-Glycolic Acid (PLGA) nanoparticles coated with chitosan to enhance Prostate-specific membrane antigen (PSMA)-specific activity against Lymph Node Carcinoma of the Prostate (LNCap) prostate tumor cells.